Pregabalin – MIMS – Expanded warning regarding drug dependence and withdrawal symptoms
01/09/2022
Medicines for human use
Safety update
This article was produced by the HPRA for publication in the September 2022 edition of Monthly Index of Medical Specialties (MIMS) and describes the expanded warning in the product information of pregabalin regarding drug dependence and withdrawal symptoms.